The DOI matches its Crossref record; 109 of the 111 references it cites were found in a registry or an index.
Atomoxetine Improved Response Inhibition in Adults with Attention Deficit/Hyperactivity Disorder
Abstract
Background Atomoxetine, a highly selective noradrenaline reuptake inhibitor (SNRI), shows efficacy in the treatment of attention-deficit/hyperactivity disorder (ADHD). Compared with psychostimulants, atomoxetine has a distinct mode of brain action and potentially lower addictive potential. Studies have yet to assess whether atomoxetine improves cognition following a single oral dose in ADHD. Methods Twenty-two adults with DSM-IV ADHD were administered a single oral dose of atomoxetine (60 mg) in a placebo-controlled double-blind crossover design. Cognitive effects were assessed using stop-signal, sustained attention, spatial working memory, and set-shifting paradigms. Normative cognitive data from 20 healthy volunteers were collected for comparison. Results The ADHD patients under placebo conditions showed response inhibition and working memory deficits compared with healthy volunteers. Atomoxetine treatment in the ADHD patients was associated with shorter stop-signal reaction times and lower numbers of commission errors on the sustained attention task. Conclusions Atomoxetine improved inhibitory control, most likely via noradrenergically mediated augmentation of prefrontal cortex function. These results have implications for understanding the mechanisms by which atomoxetine exerts beneficial clinical effects and suggest novel treatment directions for other disorders of impulsivity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In humans, both normal subjects (Chamberlain et al., 2006), and patients with ADHD (Chamberlain et al., 2007) show improved PFC inhibition of behavior following atomoxetine, consistent with the animal data.”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Chamberlain et al., 2007
In the citing paper
“Atomoxetine improves measures of PFC cognitive function in rats (Newman et al., 2008; Robinson et al., 2008; Seu et al., 2009), monkeys (Gamo et al., 2010; Seu et al., 2009), and humans (Chamberlain et al., 2007; Chamberlain et al., 2006).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Chamberlain et al., 2007
Citations
Cites
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
Statistical Methods for Psychology.
Gudgeon, A. C., & Howell, D. C. (1994) · Journal of the Royal Statistical Society Series D (The Statistician) · doi:10.2307/2348956 · Cited by 8,277
The mini international neuropsychiatric interview
Lecrubier, Y., Sheehan, D. V., Hergueta, T., & Weiller, E. (1998) · European Psychiatry · doi:10.1016/s0924-9338(99)80239-9 · Cited by 5,899
Evenden, J. L. (1999) · Psychopharmacology · doi:10.1007/pl00005481 · Cited by 2,044
Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans
Aron, A. R., Fletcher, P. C., Bullmore, E. T., Sahakian, B. J., & Robbins, T. W. (2003) · Nature Neuroscience · doi:10.1038/nn1003 · Cited by 1,771
Self-citationPrinciples of Frontal Lobe Function
Stuss, D. T. (2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134971.001.0001 · Cited by 1,731
Aron, A. R., & Poldrack, R. A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4682-05.2006 · Cited by 1,630
Attention-Deficit/Hyperactivity Disorder: A Selective Overview
Biederman, J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.020 · Cited by 1,343
MARTINUSSEN, R., HAYDEN, J., HOGG-JOHNSON, S., & TANNOCK, R. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000153228.72591.73 · Cited by 1,297
Planning and spatial working memory following frontal lobe lesions in man
Owen, A. M., Downes, J. J., Sahakian, B. J., Polkey, C. E., & Robbins, T. W. (1990) · Neuropsychologia · doi:10.1016/0028-3932(90)90137-d · Cited by 1,284
Self-citation
Research works printed but not linked: 1
- Robinson, 2006, Effects of atomoxetine on inhibitory control in the rat stop-signal task, J Psychopharmacol, 20, A67
Cited by
Sorted by citations
Items 101–200 of 289
Navarra, R. L. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.11.016 · Cited by 56
Alpha-2 Adrenergic Receptors and Attention-Deficit/Hyperactivity Disorder
Bidwell, L. C., Dew, R. E., & Kollins, S. H. (2010) · Current Psychiatry Reports · doi:10.1007/s11920-010-0136-4 · Cited by 55
Randomized Controlled Trial of Atomoxetine for Cognitive Dysfunction in Early Huntington Disease
Beglinger, L. J., Adams, W., Paulson, H. L., Fiedorowicz, J. G., Langbehn, D. R., Duff, K., Leserman, A., & Paulsen, J. S. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181b2ac0a · Cited by 52
Stevenson, M. P., & McNaughton, N. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.10.003 · Cited by 51
Arakawa, R., Okumura, M., Ito, H., Seki, C., Takahashi, H., Takano, H., Nakao, R., Suzuki, K., Okubo, Y., Halldin, C., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.051292 · Cited by 52
Kratz, O., Studer, P., Baack, J., Malcherek, S., Erbe, K., Moll, G. H., & Heinrich, H. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.008 · Cited by 55
Alkam, T., Mamiya, T., Kimura, N., Yoshida, A., Kihara, D., Tsunoda, Y., Aoyama, Y., Hiramatsu, M., Kim, H.-C., & Nabeshima, T. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4591-z · Cited by 50
The Impact of Financial Reward Contingencies on Cognitive Function Profiles in Adult ADHD
Marx, I., Höpcke, C., Berger, C., Wandschneider, R., & Herpertz, S. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067002 · Cited by 52
de Jong, C. G. W., Voorde, S. V. D., Roeyers, H., Raymaekers, R., Allen, A. J., Knijff, S., Verhelst, H., Temmink, A. H., Smit, L. M. E., Pereira, R. R., et al. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.0029 · Cited by 52
Effect of ADHD medication in male C57BL/6J mice performing the rodent Continuous Performance Test
Caballero-Puntiverio, M., Lerdrup, L., Grupe, M., Larsen, C., Dietz, A. G., & Andreasen, J. T. (2019) · Psychopharmacology · doi:10.1007/s00213-019-5167-x · Cited by 48
Blanchard, M. M., Chamberlain, S. R., Roiser, J. P., Robbins, T. W., & Müller, U. (2010) · Psychological Medicine · doi:10.1017/s003329171000098x · Cited by 51
Self-citationPattij, T., Schetters, D., Schoffelmeer, A. N. M., & van Gaalen, M. M. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2405-2 · Cited by 47
Schmeichel, B. E., & Berridge, C. W. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.6 · Cited by 43
Noradrenergic α2A-receptor stimulation in the ventral hippocampus reduces impulsive decision-making
Abela, A. R., & Chudasama, Y. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3262-y · Cited by 47
Voon, V., & Dalley, J. W. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_5013 · Cited by 46
Vriend, C. (2018) · Cell and Tissue Research · doi:10.1007/s00441-017-2771-0 · Cited by 49
Pharmacotherapy in autism spectrum disorders, including promising older drugs warranting trials
Hellings, J. A. (2023) · World Journal of Psychiatry · doi:10.5498/wjp.v13.i6.262 · Cited by 47
Parker, M. O., Brock, A. J., Sudwarts, A., & Brennan, C. H. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3439-z · Cited by 44
Sobanski, E., Sabljic, D., Alm, B., Dittmann, R., Wehmeier, P. M., Skopp, G., & Strohbeck-Kühner, P. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2012.08.001 · Cited by 42
Wilson, C. A., Schade, R., & Terry, A. V. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.040 · Cited by 40
Optimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal
Ashare, R. L., & Schmidt, H. D. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.908180 · Cited by 40
Bradshaw, S. E., Agster, K. L., Waterhouse, B. D., & McGaughy, J. A. (2016) · Brain Research · doi:10.1016/j.brainres.2016.01.001 · Cited by 42
Schmeichel, B. E., Zemlan, F. P., & Berridge, C. W. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.005 · Cited by 40
Monoaminergic modulation of behavioural and electrophysiological indices of error processing
Barnes, J. J. M., O’Connell, R. G., Nandam, L. S., Dean, A. J., & Bellgrove, M. A. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3246-y · Cited by 38
Ceravolo, R., Brusa, L., Galati, S., Volterrani, D., Peppe, A., Siciliano, G., Pierantozzi, M., Moschella, V., Bonuccelli, U., Stanzione, P., et al. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03254.x · Cited by 38
Stolerman, I. P., & Price, L. H. (2015) · Springer eBooks · doi:10.1007/978-3-642-36172-2_200815 · Cited by 36
The effects of ADHD on cognitive performance
Claesdotter, E., Cervin, M., Åkerlund, S., Råstam, M., & Lindvall, M. (2018) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2017.1402951 · Cited by 36
Bari, A., & Robbins, T. W. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_102 · Cited by 37
Self-citationShang, C., & Gau, S. S. (2012) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2011.0149 · Cited by 38
CNS Target Identification and Validation: Avoiding the Valley of Death or Naive Optimism?
Hutson, P. H., Clark, J. A., & Cross, A. J. (2016) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104624 · Cited by 35
Harvey, R. C., Jordan, C. J., Tassin, D. H., Moody, K. R., Dwoskin, L. P., & Kantak, K. M. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.01.027 · Cited by 34
Fitzgerald, P. J. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1856-1 · Cited by 36
Mar, A. C., Nilsson, S. R. O., Gamallo‐Lana, B., Lei, M., Dourado, T., Alsiö, J., Saksida, L. M., Bussey, T. J., & Robbins, T. W. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4679-5 · Cited by 31
Self-citationNonmedication treatments for adult ADHD: Evaluating impact on daily functioning and well-being.
Ramsay, J. R. (2010) · American Psychological Association eBooks · doi:10.1037/12056-000 · Cited by 33
Wilson, C., & Terry, A. V. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.12.015 · Cited by 36
Housden, C. R., Morein‐Zamir, S., & Sahakian, B. J. (2011) · Wiley eBooks · doi:10.1002/9781444393552.ch7 · Cited by 33
Self-citationKlaming, R., Simmons, A., Spadoni, A., & Lerman, I. (2020) · Neuromodulation (Malden, Mass.) · doi:10.1111/ner.13313 · Cited by 29
Seu, E., & Jentsch, J. D. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.08.007 · Cited by 32
Dissecting Impulsivity: Brain Mechanisms and Neuropsychiatric Implications
Robbins, T. W., & Dalley, J. W. (2017) · Nebraska Symposium on Motivation/The Nebraska symposium on motivation · doi:10.1007/978-3-319-51721-6_7 · Cited by 33
Self-citationGriffiths, K. R., Leikauf, J. E., Tsang, T. W., Clarke, S., Hermens, D. F., Efron, D., Williams, L. M., & Kohn, M. R. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.03.009 · Cited by 29
What do experts think we should do to achieve brain health?
Sahakian, B. J. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.04.002 · Cited by 31
Self-citationGerber, W., Müller, G. G.-V., Andrasik, F., Niederberger, U., Siniatchkin, M., Kowalski, J. T., Petermann, U., & Petermann, F. (2011) · Child Neuropsychology · doi:10.1080/09297049.2011.599115 · Cited by 29
Sterley, T.-L., Howells, F. M., & Russell, V. A. (2012) · Brain Research · doi:10.1016/j.brainres.2012.12.029 · Cited by 32
Arnsten, A. F. T. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1274-9 · Cited by 32
Froestl, W., Pfeifer, A., & Muhs, A. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121729 · Cited by 27
Cognition and serotonin in Parkinson's disease
Frouni, I., Kwan, C., Belliveau, S., & Huot, P. (2022) · Progress in brain research · doi:10.1016/bs.pbr.2022.01.013 · Cited by 32
Simone, J. J., Green, M. R., Hodges, T. E., & McCormick, C. M. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.11.012 · Cited by 30
Nandam, L. S., Hester, R., & Bellgrove, M. A. (2014) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2014.01.023 · Cited by 27
Pharmacological treatment of cognitive deficits in nondementing mental health disorders
Robbins, T. W. (2019) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2019.21.3/trobbins · Cited by 30
Self-citationAnker, J. J., Zlebnik, N. E., Gliddon, L. A., & Carroll, M. E. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283305ea2 · Cited by 28
Using ADHD Medications to Treat Coexisting ADHD and Reading Disorders: A Systematic Review
Froehlich, T. E., Fogler, J., Barbaresi, W. J., Elsayed, N. A., Evans, S. W., & Chan, E. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1192 · Cited by 28
Reduced Neural Error Signaling in Left Inferior Prefrontal Cortex in Young Adults With ADHD
Vasić, N., Plichta, M. M., Wolf, R. C., Fallgatter, A. J., Sosic-Vasic, Z., & Grön, G. (2012) · Journal of Attention Disorders · doi:10.1177/1087054712446172 · Cited by 26
Anything goes? Regulation of the neural processes underlying response inhibition in TBI patients
Moreno-López, L., Manktelow, A. E., Sahakian, B. J., Menon, D. K., & Stamatakis, E. A. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.12.002 · Cited by 26
Self-citationThe effect of methylphenidate and rearing environment on behavioral inhibition in adult male rats
Hill, J. C., Covarrubias, P., Terry, J., & Sanabria, F. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2552-5 · Cited by 27
Yamamuro, K., Ota, T., Iida, J., Nakanishi, Y., Matsuura, H., Uratani, M., Okazaki, K., Kishimoto, N., Tanaka, S., & Kishimoto, T. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.05.061 · Cited by 27
Higgins, G. A., Silenieks, L. B., MacMillan, C., Thevarkunnel, S., Parachikova, A. I., Mombereau, C., Lindgren, H. S., & Bastlund, J. F. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00427 · Cited by 26
Caballero-Puntiverio, M., Lerdrup, L., Arvastson, L., Aznar, S., & Andreasen, J. T. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109823 · Cited by 23
The effect of noradrenergic attenuation by clonidine on inhibition in the stop signal task
Logemann, H. N. A., Böcker, K. B. E., Deschamps, P. K. H., Kemner, C., & Kenemans, J. L. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.06.007 · Cited by 24
Nakanishi, Y., Ota, T., Iida, J., Yamamuro, K., Kishimoto, N., Okazaki, K., & Kishimoto, T. (2017) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-017-0163-6 · Cited by 24
The effects of methylphenidate on cerebral activations to salient stimuli in healthy adults.
Farr, O. M., Hu, S., Matuskey, D., Zhang, S., Abdelghany, O., & Li, C. R. (2013) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0034465 · Cited by 24
Giraudier, M., Ventura‐Bort, C., & Weymar, M. (2024) · Brain Sciences · doi:10.3390/brainsci14070690 · Cited by 21
Ni, H., Gu, S.-L. H., Lin, H., Lin, Y., Yang, L.-K., Huang, H., & Gau, S. S. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116632377 · Cited by 22
Neuropsychiatric Aspects of Impulse Control Disorders
Silva, B., Canas‐Simião, H., & Cavanna, A. E. (2020) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2020.02.001 · Cited by 22
Broos, N., Loonstra, R., van Mourik, Y., Schetters, D., Schoffelmeer, A. N. M., Pattij, T., & Vries, T. J. D. (2014) · Addiction Biology · doi:10.1111/adb.12168 · Cited by 21
Phillips, A. G., Geyer, M. A., & Robbins, T. W. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.01.014 · Cited by 21
Self-citationSilveira, M. M., Murch, W. S., Clark, L., & Winstanley, C. A. (2015) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000203 · Cited by 22
Self-citationIncreased Cortisol after Stress is Associated with Variability in Response Time in ADHD Children
Lee, S. H., Shin, D., & Stein, M. A. (2010) · Yonsei Medical Journal · doi:10.3349/ymj.2010.51.2.206 · Cited by 18
Advances in the Pharmacotherapy of Attention-Deficit/Hyperactivity Disorder
Kollins, S. H., & March, J. S. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.08.009 · Cited by 18
Song, D., Jhung, K., Song, J., & Cheon, K.-A. A. (2011) · Behavioral and Brain Functions · doi:10.1186/1744-9081-7-12 · Cited by 18
The Cambridge Neuropsychological Test Automated Battery in the Assessment of Executive Functioning
Wild, K. V., & Musser, E. D. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8106-5_11 · Cited by 21
Mama, Y., & Icht, M. (2018) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617718001017 · Cited by 17
Atomoxetine in abstinent cocaine users: Cognitive, subjective and cardiovascular effects
DeVito, E. E., Herman, A. I., Konkus, N. S., Zhang, H., & Sofuoglu, M. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.07.002 · Cited by 17
Benegal, V., Viswanath, B., Narayanaswamy, J. C., Jose, S. P., Chakraborty, V., Sankar, D., Thennarasu, K., & Kesavan, M. (2013) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2013.07.007 · Cited by 16
Safety of Atomoxetine in Combination With Intravenous Cocaine in Cocaine-Experienced Participants
Cantilena, L. R., Kahn, R., Duncan, C. C., Li, S.-H., Anderson, A., & Elkashef, A. M. (2012) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e31826b767f · Cited by 16
Mückschel, M., Roessner, V., & Beste, C. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.03.013 · Cited by 16
Zhukovsky, P., Morein‐Zamir, S., Ziauddeen, H., Fernández-Egea, E., Meng, C., Regenthal, R., Sahakian, B. J., Bullmore, E. T., Robbins, T. W., Dalley, J. W., et al. (2021) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2021.08.010 · Cited by 14
Self-citationThe Neurobiological Basis of Attention-Deficit/Hyperactivity Disorder
Arnsten, A. F. T., Berridge, C. W., & McCracken, J. T. (2009) · Primary psychiatry · Cited by 14
Effects of nicotine and atomoxetine on brain function during response inhibition
Kasparbauer, A., Petrovsky, N., Schmidt, P.-M., Trautner, P., Weber, B., Sträter, B., & Ettinger, U. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.12.004 · Cited by 14
Validation of a method to assess ADHD-related impulsivity in animal models
Watterson, E., Mazur, G. J., & Sanabria, F. (2015) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2015.03.020 · Cited by 13
Evidence for a role of corticopetal, noradrenergic systems in the development of executive function
Mokler, D. J., Miller, C. E., & McGaughy, J. A. (2017) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2017.02.011 · Cited by 12
Open-Label Trial of Atomoxetine Hydrochloride in Adults With ADHD
Johnson, M., Cederlund, M., Råstam, M., Areskoug, B., & Gillberg, C. (2010) · Journal of Attention Disorders · doi:10.1177/1087054709332372 · Cited by 18
Noradrenergic therapies in neurodegenerative disease: from symptomatic to disease modifying therapy?
Durcan, R., O’Callaghan, C., & Rowe, J. B. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf310 · Cited by 15
del Campo, N., Tait, R. J., Acosta‐Cabronero, J., Hong, Y. T., Izquierdo‐Garcia, D., Smith, R., Aigbirhio, F. I., Sahakian, B. J., Müller, U., Robbins, T. W., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.11.071 · Cited by 12
Self-citationChronic Pain Produces Reversible Memory Deficits That Depend on Task Difficulty in Rats
Phelps, C. E., Navratilova, E., & Porreca, F. (2021) · Journal of Pain · doi:10.1016/j.jpain.2021.04.016 · Cited by 12
Ye, R., Hezemans, F. H., O’Callaghan, C., Tsvetanov, K. A., Rua, C., Jones, P. S., Holland, N., Malpetti, M., Murley, A. G., Barker, R. A., et al. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0289-22.2023 · Cited by 15
Self-citationKang, D., Song, C., Peng, X., Guo, Y., Yang, Y., Chen, C., Long, Y., Shao, P., & Wu, R. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02770-w · Cited by 12
Current nonstimulant medications for adults with attention-deficit/hyperactivity disorder
Brancati, G. E., Magnesa, A., Acierno, D., Carli, M., Rosa, U. D., Froli, A., Gemignani, S., Ventura, L., Weiss, F., & Perugi, G. (2024) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2024.2370346 · Cited by 16
Rush, C. R., Stoops, W. W., Lile, J. A., Glaser, P. E. A., & Hays, L. R. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.06.024 · Cited by 11
Lei, X., Chen, C., He, Q., Moyzis, R. K., Xue, G., Chen, C., Cao, Z., Li, J., Li, H., Zhu, B., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.266 · Cited by 11
Pharmacological cognitive enhancers
Peltier, M. R., & Sofuoglu, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815298-0.00023-x · Cited by 9
Zack, M., Boileau, I., Payer, D., Chugani, B., Lobo, D., Houle, S., Wilson, A., Warsh, J., & Kish, S. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115592338 · Cited by 10
Selective noradrenaline reuptake inhibitors for schizophrenia
Matthews, P., Horder, J., & Pearce, M. J. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010219.pub2 · Cited by 9
Silverstone, P. H., & Dadashova, R. (2012) · Annals of General Psychiatry · doi:10.1186/1744-859x-11-6 · Cited by 9
Newman, L. A., Baraiolo, J., Mokler, D. J., Rabinowitz, A. G., Galler, J. R., & McGaughy, J. A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00123 · Cited by 10
Liu, Q., Xu, X., Cui, H., Zhang, L., Zhao, Z., Dong, D., & Shen, Y. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.858465 · Cited by 8
Methylphenidate has nonlinear dose effects on cued response inhibition in adults but not adolescents
Simon, N. W., & Moghaddam, B. (2016) · Brain Research · doi:10.1016/j.brainres.2016.07.027 · Cited by 10
Zoratto, F., Franchi, F., Macrı̀, S., & Giovanni Laviola, A. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05229-9 · Cited by 8
Giller, F., Aggensteiner, P.-M., Banaschewski, T., Döpfner, M., Brandeis, D., Roessner, V., & Beste, C. (2021) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2021.03.014 · Cited by 10
Mackenzie, G. (2018) · Journal of ADHD And Care · doi:10.14302/issn.3066-8042.jac-17-1843 · Cited by 11
Metadata
- Authors
- Chamberlain, S. R., del Campo, N., Dowson, J., Müller, U., Clark, L., Robbins, T. W., & Sahakian, B. J.
- Affiliations
- University of Cambridge (GB)
- Utrecht University (NL)
- Corresponding author
- Chamberlain, Samuel R.
- ORCID
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 62
- Issue
- 9
- Pages
- 977-984
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W2005105013
- Cited by
- 288
- References
- 111
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 6 · 2023: 9 · 2022: 8 · 2021: 12 · 2020: 8 · 2019: 11 · 2018: 8 · 2017: 15 · 2016: 17 · 2015: 13 · 2014: 27 · 2013: 27 · 2012: 30
- FWCI
- 12.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Funders
- Wellcome Trust (076274/Z04/Z)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- atomoxetine, attention deficit hyperactivity disorder, adults, response inhibition, inhibitory control, norepinephrine reuptake inhibitors, single-dose pharmacokinetics, stop-signal task, sustained attention, spatial working memory, set-shifting, prefrontal cortex, impulsivity, cognitive effects
- MeSH terms
- Atomoxetine Hydrochloride, Administration, Oral, Adult, Analysis of Variance, Attention, Attention Deficit Disorder with Hyperactivity, Cognition, Double-Blind Method, Female, Humans, Inhibition, Psychological, Male, Memory, Short-Term, Neuropsychological Tests, Propylamines, Reaction Time, Time Factors, Case-Control Studies, Cross-Over Studies, Adrenergic Uptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
